These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8797135)

  • 1. Effects of ramipril and enalapril on cerebral blood flow in elderly patients with asymptomatic carotid artery occlusive disease.
    Patel RV; Ramadan NM; Levine SR; Welch KM; Fagan SC
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):48-52. PubMed ID: 8797135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of isradipine and enalapril effects on regional carotid circulation in patients with hypertension with unilateral internal carotid artery stenosis.
    Akopov SE; Simonian NA
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):562-70. PubMed ID: 9388037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood flow changes with enalapril.
    Fagan SC; Robert S; Ewing JR; Levine SR; Ramadan NM; Welch KM
    Pharmacotherapy; 1992; 12(4):319-23. PubMed ID: 1518729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in cough reflex after treatment with enalapril and ramipril.
    McEwan JR; Choudry N; Street R; Fuller RW
    BMJ; 1989 Jul; 299(6690):13-6. PubMed ID: 2547470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G
    Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off.
    Demolis P; Chalon S; Annane D; Duhaze P; Giudicelli JF
    Br J Clin Pharmacol; 1992 Sep; 34(3):224-30. PubMed ID: 1327051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the effects of antihypertensive medication on cerebral blood flow: demonstration in internal carotid artery occlusion.
    Fagan SC; Ewing JR; Levine SR; Tietjen GE; Ramadan NM; Welch KM
    DICP; 1991 Dec; 25(12):1299-301. PubMed ID: 1815420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood flow and antihypertensive treatment with enalapril.
    Frei A; Müller-Brand J
    J Hypertens; 1986 Jun; 4(3):365-7. PubMed ID: 2874175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ramipril and enalapril in patients with essential hypertension.
    Ruddy MC; Mroczek WJ
    Pharmacotherapy; 1993; 13(3):224-8. PubMed ID: 8321736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril.
    MacMahon S; Sharpe N; Gamble G; Clague A; Mhurchu CN; Clark T; Hart H; Scott J; White H
    J Am Coll Cardiol; 2000 Aug; 36(2):438-43. PubMed ID: 10933355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of enalapril maleate on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S; Yamaguchi S; Okada K; Suyama N; Bokura K; Murao M
    Angiology; 1992 May; 43(5):378-88. PubMed ID: 1567061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
    Napoli C; Bruzzese G; Ignarro LJ; Crimi E; de Nigris F; Williams-Ignarro S; Libardi S; Sommese L; Fiorito C; Mancini FP; Cacciatore F; Liguori A
    Am Heart J; 2008 Dec; 156(6):1154.e1-8. PubMed ID: 19033012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
    Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ramipril in elderly patients with mild and moderate hypertension. Clinical efficacy, effect on cerebral blood flow and intellectual functioning].
    Pogosova GV; Zhidko NI; Ivanishina NS; Gudkova OA; Avakian GN
    Kardiologiia; 2003; 43(6):42-7. PubMed ID: 12891310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study.
    Fröhlich H; Henning F; Täger T; Schellberg D; Grundtvig M; Goode K; Corletto A; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Frankenstein L; Clark AL
    Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):82-92. PubMed ID: 28475676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
    Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
    J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats.
    Wahlander H; Sohtell M; Wickman A; Nilsson A; Friberg P
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):327-34. PubMed ID: 8907793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.